(MENAFN- GlobeNewsWire - Nasdaq) CRO opportunities center on outsourced, end-to-end services, personalized medicine, AI, decentralized trials, real-world data, oncology, rare diseases and Asia-Pacific expansion.Dublin, Sept. 15, 2026 (GLOBE NEWSWIRE) -- "Clinical Research Organization Market Report 2026" has been added to ResearchAndMarkets.com's offering.
Clinical Research Organization Market to Reach $103.56 Billion by 2030 as Personalized Medicine and AI Adoption Accelerate
The global clinical research organization market is experiencing strong growth as pharmaceutical, biotechnology and medical device companies increasingly outsource clinical development activities. The market is projected to grow from $65.34 billion in 2025 to $71.82 billion in 2026, representing a compound annual growth rate (CAGR) of 9.9%. Historical growth has been supported by expanding pharmaceutical research pipelines, rising global clinical trial volumes, increasingly complex regulatory requirements and growing demand for specialized clinical research expertise.
Looking ahead, the clinical research organization market is forecast to reach $103.56 billion by 2030, expanding at a CAGR of 9.6%. Growth during the forecast period is expected to be driven by demand for faster drug development, increased use of artificial intelligence in clinical trial optimization, expansion of personalized medicine studies, greater emphasis on real-world evidence and the continued globalization of clinical research. Decentralized clinical trials, advanced data analytics, end-to-end CRO services and increased research activity in oncology and rare diseases are also expected to shape the market.
The rising demand for personalized medicine is a key factor supporting clinical research organization market growth. Advances in genomics and biotechnology are enabling the development of more targeted therapies based on patients' genetic and biological profiles. CROs support this process by managing specialized clinical trials, analyzing complex data and helping sponsors meet regulatory requirements. In February 2024, the Personalized Medicine Coalition reported that the U.S. Food and Drug Administration approved 16 novel personalized therapies for patients with rare diseases in 2023, up from six approvals in 2022. This increase highlights the expanding need for specialized research capabilities and trial management services.
Technology adoption is transforming the clinical research organization industry, with providers investing in AI-driven platforms that improve data integration, analysis and clinical trial efficiency. In January 2023, Elligo Health Research Inc. launched DataAI Connect, an end-to-end platform designed to accelerate data-driven clinical research. The platform supports the collection, management, analysis and sharing of real-world patient data while enabling medical record retrieval and analysis. Such solutions can help research sponsors address fragmented data, improve study planning and generate actionable insights throughout the clinical development lifecycle.
Strategic acquisitions are also strengthening service portfolios and extending the geographic reach of CRO providers. In March 2024, India-based Veeda Clinical Research Ltd. acquired Ireland-based Heads for an undisclosed amount. The transaction expanded Veeda's contract research capabilities across the drug development lifecycle, including discovery, clinical development and post-commercial launch services. It also enhanced the company's ability to support clients conducting early- and late-phase clinical trials.
Clinical research organizations provide services across drug discovery, preclinical development, clinical trials and post-approval research. Demand spans therapeutic areas including oncology, central nervous system disorders, cardiovascular diseases, metabolic conditions, immunology, respiratory diseases, musculoskeletal disorders and hematological conditions. CRO services are used by pharmaceutical and biotechnology companies, medical device manufacturers, government and private organizations, and academic institutions. Core services include clinical trial management, biostatistics, data management, medical writing, pharmacovigilance, patient recruitment, clinical monitoring, quality assurance and regulatory compliance.
North America was the largest region in the clinical research organization market in 2025, supported by extensive pharmaceutical research activity, established healthcare infrastructure and significant clinical development investment. Asia-Pacific is expected to be the fastest-growing region during the forecast period as clinical trial activity expands and regional research capabilities improve. The market coverage includes Asia-Pacific, Southeast Asia, Western Europe, Eastern Europe, North America, South America, the Middle East and Africa. Countries analyzed include Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, the United Kingdom, the United States, Canada, Italy and Spain.
Markets Covered:
1) By Service: Drug Discovery Services; Pre-Clinical Services; Clinical Services; Post Approval Services
2) By Production: In-house; Outsourced
3) By Indication: Oncology; Central Nervous System; Cardiovascular Diseases; Metabolic Disorders; Immunology; Respiratory; Musculoskeletal Disorders; Hematological Disorders
4) By End User: Pharmaceutical And Biotechnology Companies; Medical Device Companies; Governments And Private Firms; Academic Institutions; Other End Users
Subsegments:
1) By Drug Discovery Services: Target Identification and Validation; Lead Optimization; Preclinical Development; Biomarker Discovery
2) By Pre-Clinical Services: Toxicology Studies; Pharmacokinetics and Pharmacodynamics; Animal Model Studies; GLP (Good Laboratory Practice) Studies
3) By Clinical Services: Phase I Trials; Phase II Trials; Phase III Trials; Clinical Trial Management; Regulatory Affairs
4) By Post Approval Services: Phase IV Studies; Post-Market Surveillance; Safety Monitoring and Reporting; Market Access and Health Economics Services
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Key Attributes:
CONTACT:
CONTACT: ResearchAndMarkets.com
Laura Wood,Senior Press Manager...
For E.S.T Office Hours Call 1-917-300-0470
For U.S./ CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Comments
No comment